Contract research organization services are designed to provide support to the pharmaceutical, biotechnology, and medical device industries in the form of research outsourced on a contract basis. It is also known as a clinical research organization. A contract research organization service includes product development, formulation, and manufacturing, clinical trial management, medical and safety monitoring. CROs specifically provide support to drug and medical devices. CRO helps to support a certain part of the drug development process. These make the process easier, faster and provide access to patients and investigators. Therefore, CROs are hired on contract basis for improvement in drug development. Moreover, technological development in a healthcare monitoring device for better treatment of patients has given a positive impact on the growth of the global contract research organization services market over the forecast period of 2017- 2025.
The global contract research organization services market is propelled by the increasing investment in biopharmaceutical research and development. geriatric population and for the robust prevalence of cardiac disorders. Further, technological advancement for improving the healthcare monitoring devices are the important factor for making this market more demanding in the estimated period. Another prime issue which is driving the market is increasing rates of pipeline drugs coupled with the rise in subcontracting of laboratory and need for improved pharmaceutical services in developing countries like China, India, and Brazil among others. Additionally, robust demand for specialized testing service also creates a huge growth opportunity for the market in the upcoming years.
The global Contract Research Organization Services market in the report is segmented by type which includes clinical research services, preclinical research services, analytical testing services, bioanalytical testing services, stability testing, consulting services, and others. Based on the application the market is analyzed as diabetes, oncology, cardiovascular diseases, central nervous system disorders, and others. Moreover, the global contract research organization services have been geographically segmented into North America, Europe, Asia-Pacific, Middle East and Africa and Latin America.
In addition to this, increasing number of infrastructure projects and fast-growing healthcare industries in Asia-Pacific, makes the region held the largest market share. Moreover, increasing investment by the key vendors for the development of pharmaceutical manufacturing with the help of technological advancement and low-cost treatment features are mainly driving the European and North America market. Moving forward, rising prevalence geriatric population in the U.S., Germany, Italy, and France, has therefore increased the demand for the contract research organization services in this region. Furthermore, the rapid growth of pharmaceutical and biopharmaceutical industry in countries like Brazil and Chile, therefore, creates a high demand for contract research organization services in Latin-America region. Likewise, new infrastructure for research and development projects augmented the demand for this market in the Middle East and Africa region.
However, lack of skilled authorities and strong competition among the key players may impose a restriction on the growth of the global contract research organization services market.
Some of the major players in the global Contract Research Organization Services include Charles RiveI, Envigo, IQVIA, ICON PLC, LabCorp, MeDPAce Holdings, MPI Research, PRA Health Sciences, and WUXI Pharmatech.
Global Contract Research Organization Services Market: By Type
Global Contract Research Organization Services Market: By Application
Global Contract Research Organization Services Market: By Geography